WINNERS & LOSERS: Eleco buyout; boohoo jumps on Primark site deal
10th Sep 2026 10:43
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More
| Price | 430.50p on 14-09-2026 at 10:35:11 |
|---|---|
| Change | -6.50p -1.49% |
| Buy | 449.50p |
| Sell | 440.00p |
| Last Trade: | Sell 1,143.00 at 438.22p |
| Day's Volume: | 31,753 |
| Last Close: | 437.00p |
| Open: | 479.50p |
| ISIN: | GB00BQVXM815 |
| Day's Range | 430.50p - 479.50p |
| 52wk Range: | 390.00p - 1,790.00p |
| Market Capitalisation: | £29.69m |
| VWAP: | 444.89378p |
| Shares in Issue: | 6.90m |
Sector: Medicine and Biotech
Hemogenyx Pharmaceuticals (HEMO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1,143 | 438.22p | Negotiated Trade |
11:34:17 - 14-Sep-26 |
| Sell* | 1,750 | 444.2646p | Ordinary |
11:34:05 - 14-Sep-26 |
| Sell* | 1,750 | 444.2646p | Ordinary |
11:34:05 - 14-Sep-26 |
| Buy* | 10 | 450.00p | SI Trade |
11:27:06 - 14-Sep-26 |
| Sell* | 1,001 | 447.00p | Ordinary |
11:10:02 - 14-Sep-26 |
| Sell* | 1,250 | 447.00p | Ordinary |
11:09:50 - 14-Sep-26 |
| Sell* | 1,250 | 447.00p | Ordinary |
11:09:50 - 14-Sep-26 |
| Sell* | 2,500 | 451.1948p | Ordinary |
11:05:40 - 14-Sep-26 |
| Sell* | 2,500 | 451.1948p | Ordinary |
11:05:40 - 14-Sep-26 |
| Sell* | 200 | 447.00p | Ordinary |
11:00:21 - 14-Sep-26 |
Hemogenyx Pharmaceuticals (HEMO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Sep 2026 7:00 am | RNS | Exercise of Warrants and Issue of Equity |
| 11th Aug 2026 7:00 am | RNS | Collaboration with Cellin Technologies |
| 29th Jul 2026 7:00 am | RNS | Collaboration and Company Update |
| 1st Jul 2026 7:00 am | RNS | Result of AGM |
| 5th Jun 2026 7:00 am | RNS | Notice of AGM |
| 29th May 2026 9:18 am | RNS | Grant of Options and Extension of Warrant Term |
| 30th Apr 2026 4:04 pm | RNS | Final Results |
| 28th Apr 2026 7:00 am | RNS | Institutional Fundraise |
| 14th Apr 2026 7:00 am | RNS | Annual IND Report with FDA |
| 31st Mar 2026 1:22 pm | RNS | Tech Transfer Completion and Clinical Trial Update |